$BNTX
SEC EDGAR Filings Hub
2 Filings
$BNTX · BioNTech SE SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for BioNTech SE ($BNTX) from November 3, 2026 through November 3, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 0 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $BNTX portfolio concentration →
View $BNTX Congress trades →
Research $BNTX stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports0
8-K Material Events0
Form 4 Insider0
High-Impact2
Latest FilingNovember 3, 2026
Browse SEC Filings by Form Type
Latest $BNTX SEC Filings & AI Summaries (2)
November 3, 2026
$BNTX 6-K — BioNTech SE
BioNTech delivered a return to quarterly profitability alongside a guidance raise, signaling that its oncology pipeline momentum and cost discipline are beginning to offset decl…
November 3, 2026
$BNTX 6-K — BioNTech SE
BioNTech's swing to quarterly profit after heavy losses signals operational leverage improving, but the €1.17B nine-month loss and pending EP'949 patent ruling keep risk elevated.
Related & Peer Company SEC Filing Hubs